• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Protalix BioTherapeutics Inc - Articles and news items

Pfizer logo

Pfizer and Protalix BioTherapeutics announce FDA approval of pediatric Indication for ELELYSO™ (taliglucerase alfa) for injection

Industry news / 29 August 2014 / Pfizer

…for intravenous use for the treatment of type 1 Gaucher disease.

Pfizer logo

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringWATCH NOW
+ +